Cocaine causes atrial purkinje fiber damage

Ultrastructural Pathology

Volumn 34, Issue 2, 2010, Pages 90-98

  Gilloteaux, Jacques ^a,b   Ekwedike, Nelson N ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Summa Research Foundation   (United States)

Author keywords

Arrhythmia; Cell death; Cocaine; Cytotoxicity; Heart; Purkinje myofiber; Syrian hamster

Indexed keywords

COCAINE; VASOCONSTRICTOR AGENT;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; HAMSTER; HEART ATRIUM; HEART MUSCLE CELL; LONGEVITY; MALE; PATHOLOGY; PREGNANCY; PURKINJE FIBER; SYRIAN HAMSTER; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; COCAINE; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; HEART ATRIA; LONGEVITY; MALE; MATERNAL-FETAL EXCHANGE; MESOCRICETUS; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCYTES, CARDIAC; PREGNANCY; PURKINJE FIBERS; VASOCONSTRICTOR AGENTS;

MESOCRICETUS AURATUS;

EID: 77749237138     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913121003626663     Document Type: Article

References (106)

1. Degenhardt L, Chiu WT, Sampson N, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5:1053-1067.
2. NIDA Research Monograph. Clouet D, Asghar K, Brown R, eds. Mechanisms of Cocaine Abuse and Toxicity. U.S. Dept. Health and Human Services PHS. 1989;88:304-324.
3. World Drug Report 2009. United Nations Office on Drugs and Crime (UNODC). Cocaine. 2009; pp. 69-94. www.unodc.org/pdf.
4. Zuccato E, Chiabrando C, Castiglioni S, Bagnati R, Fanelli R. Estimating community drug abuse by wastewater analysis. Environ Health Perspect. 2008;116:1027-1032.
5. Cecinato A, Balducci C, Nervegna G. Occurrence of cocaine in the air of the world's cities: an emerging problem? A new tool to investigate the social incidence of drugs. Sci Total Environ. 2009;407:1683-1690.
6. Zuo Y, Zhang K, Wu J, Rego C, Fritz J. An accurate and nondestructive GC method for determination of cocaine on US paper currency. J Sep Sci. 2008;31:2444-2450.
7. Goldstein PJ, et al. Closing the Gap: The burden of unnecessary illness. In: Amler RW, Dull HB, eds. Drug Dependence and Abuse. New York: Oxford University Press; 1987: 89-101.
8. SAMHSHA (Substance Abuse & Mental Health Services Administration). National Survey on Drugs & Health: results from the 2007 National Survey on Drug Use and Health - national findings, 2008. www.oas.samhsa.gov/researchers. cfm.
9. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320:762-768.
10. Havens JR, Simmons LA, Shannon LM, Hansen WF. 2009. Factors associated with substance use during pregnancy: results from a national sample. Drug Alcohol Depend. 2009;99:89-95.
11. Chasnoff IJ, Burnes WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-669.
12. Lindenberg CS, Alexander EM, Gendrop SC, Nencioli M, Williams DG. A review of the literature on cocaine abuse in pregnancy. Nurs Res. 1991;40:69-75.
13. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006;108:1005-1016.
14. Singer LT, Garber R, Kliegman R. Neurobehavioral sequelae of fetal cocaine exposure. J Pediatr. 1991;119:667-672.
15. Singer L, Karkas K, Kliegman R. Childhood medical and behavioural consequences of maternal cocaine use. J Pediatr Psychol. 1992;17:389-406.
16. Roland EH, Volpe JJ. Effect of maternal cocaine use on the fetus and newborn: review of the literature. Pediatr Neurosci. 1989;15:88-94.
17. Slutsker L Risks associated with cocaine use during pregnancy. Obstet Gynecol. 1992;77:778-789.
18. Wolfe El, Davis T, Guydish J, Delucchi KL. Mortality risk associated with perinatal drug and alcohol use in California. J Psychoactive Drugs. 2005;36:379-386.
19. Huestis MA, Choo RE. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int. 2002;128:20-30.
20. Kuczkowski KM. Drug addiction in pregnancy and pregnancy outcome: a call for global solutions. Subst Use Misuse. 2005;40:1749-1750.
21. Kuczkowski KM. Peripartum care of the cocaine-abusing parturient: are we ready? Acta Obstet Gynecol Scand. 2005;84:108-116.
22. Askin DF, Diehl-Jones B. Cocaine: effects of in uetro exposure on the fetus and neonate. Perinat Neonatal Nurs. 2001;14:83-102.
23. Ogunyemi D, Hernandez-Loera GE. The impact of antenatal cocaine use on maternal characteristics and neonatal outcomes. J Matern Fetal Neonatal Med. 2004;15:253-259.
24. Gilloteaux J, Dalbec J. Cocaine cardiotoxicity during development I. Mol Cell Cardiol. 1990;22 (Suppl Ill): S45.
25. Gilloteaux J, Dalbec JP. Transplacental cardiotoxicity of cocaine: atrial damage following treatment in early pregnancy. Scanning Microsc Intern. 1991;5:519-531.
26. Critchley HOD, Woods SM, Barson AJ, Richardson T, Lieberman BA. Fetal death in utero and cocaine abuse: case report. Br J Obstet Gynecol. 1988;95:195-196.
27. Chouteau M, Namerow PB, Leppert P. The effect of cocaine abuse on birth weight and gestational age. Obstet Gynecol 1988;72:351-354.
28. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320:762-768.
29. Chasnoff IJ, Burnes WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-669.
30. Chasnoff IJ, Schnoll SH. Consequences of cocaine and other drug use in pregnancy. In: Washton AM, Gold MS, eds. Cocaine: A Clinician Handbook. New York: Guilford Press; 1987: 241-251.
31. Sturner WQ, Sweeney KG, Callery RT, Haley NR. Cocaine babies: the scourge of the 90's. J Forensic Sci. 1991;36:34-39.
32. Woods JR, Plessinger MA. Pregnancy increases cardiovascular toxicity to cocaine. Am J Obstet Gynecol. 1990;162:529-533.
33. Van de Bor M, Walther FG, Ebrahimi M. Decreased cardiac output in infant of mothers who abused cocaine. Pediatrics. 1990;85:30-32.
34. Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther. 1981;217:350-356.
35. Geaty N. Cocaine: animal research studies. In: Spitz HI, Rosecan JS, eds. Cocaine Abuse: New Directions In Treatment and Research. New York: Brunner/Mazel; 1987: 19-47.
36. Nunez EV, Klein DF. Research issues in cocaine abuse: future directions. In: Spitz HI, Rosecan JS, eds. Cocaine Abuse: New Directions In Treatment and Research. New York: Brunner/Mazel; 1989: 273-298.
37. Billman GE. Mechanisms responsible for the cardiotoxic effects of cocaine. FASEB J. 1990;4:2469-2475.
38. Church MW, Dincheff BA, Gessner PK. Dose-dependent consequences of cocaine on pregnancy outcome in the Long-Evans rat. Neurotoxicol Teratol. 1988;10:105-120.
39. Zhao Y, Sun L. Perinatal cocaine exposure reduces myo-cardial norepinephrine transporter function in the neonatal rat. Neurotoxicol Teratol. 2004;26:443-450.
40. Hayes SN, Moyer TP, Morley D, Bove AA. Intravenous cocaine causes epicardial coronary vasoconstriction in the intact dog. Am Heart J. 1991;121:1639-1648.
41. Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9:177-196.
42. Gilloteaux J. Ultrastructural aspects of atrium development: demonstration of endocardial discontinuities and immunolabeling of atrial natriuretic factor in the Syrian hamster. Anat Embryol (Berl). 1989;179:227-236.
43. Gilloteaux J, Linz D. Endocardial surface and atrial morphological changes during development and aging. Am J Anat. 1989;186:161-172.
44. Gilloteaux J, Linz D. Endocardial surface changes during atrium development: a TEM, SEM, and ANF immunolabeling. In: Embryonic origins of defective heart development. Ann N Y Acad Sci. 1990;588:373-376.
45. Gilloteaux J, Bissler J, Jarjoura D, Kondolios P. Cardiomyocyte aging and hypertrophy: atrial and ventricular changes in normal and myopathic Syrian hamsters. J Submicrosc Cytol Pathol. 1990;22:249-264.
46. Gilloteaux J. Endocardial endothelium damage in congestive heart failure: pathophysiological implications. Mol Cell Cardiol. 1990;22 (Suppl Ill): S93.
47. Meyer K. D., Zhang L. Short- and long-term adverse effects of cocaine abuse during pregnancy on the heart development. Ther Adv Cardiovasc Dis. 2009;3:7-16.
48. Ebrahim Sh, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol. 2003;101:374-379.
49. Gilloteaux J, Jamison JM, Neal DR, Loukas N, Doberzstyn T, Summers JL. Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment by ascorbate and menadione. Ultrastruct Pathol. 2009;(in press).
50. Eiden RD, McAuliffe S, Kachadourian L, Coles C, Colder C, Schuetze P. Effects of prenatal cocaine exposure on infant reactivity and regulation. Neurotoxicol Teratol. 2009;31:60-68.
51. Zachor D, Cherkes JK, Fay CT, Ocrant I. Cocaine differentially inhibits neuronal differentiation and proliferation in vitro. J Clin Invest. 1994;93:1179-1185.
52. Lester BM, Padbury JF. Third pathophysiology of prenatal cocaine exposure. Dev Neurosci. 2009;31:23-35.
53. Velez NM, Garcia IE, Garcia L, Valcarcel M. The use of illicit drugs during pregnancy among mothers of premature infants. P R Health Sci J. 2008;27:209-212.
54. DeVane CL, Simpkins JW, Miller RL, Braun SB. Tissue distribution of cocaine in the pregnant rat. Life Sci. 1989;45, 1271-1276.
55. Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med. 2005;159:824-834.
56. Schenker S, Yang Y, Johnson RF, et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther. 1993;53:329-339.
57. Malek A, Obrist C, Wenzinger S, von Mandach U. The impact of cocaine and heroin on the placental transfer of methadone. Reprod Biol Endocrinol. 2009;7:61.
58. Schachne J, Roberts BH, Thompson PD. Coronary artery spam and myocardial infarction with cocaine use. N Engl J Med. 1984;310:1625-1626.
59. Vitullo JC, Karam R, Mrjhail N, Wicker P, Engelmann GL, Khairallah PA. Cocaine-induced small vessel spasm in isolated rat hearts. Am J Pathol. 1989;135:85-91.
60. Schachne J, Roberts BH, Thompson PD. Coronary artery spasm and myocardial infarction with cocaine use. N Engl J Med. 1984;310:1625-1626.
61. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562.
62. Isner JM, Chokshi SK. Cocaine and vasospasm. N Engl J Med. 1989;321:1604-1606.
63. Woods JR, Plessinger MA. Pregnancy increases cardiovascular toxicity to cocaine. Am J Obstet Gynecol. 1990;162:529-533.
64. Kloner RA, Hale S, Alker K, Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation. 1992;85:407-419.
65. Hendrix-Munoz KD, Gerrets RP, Higgins RD, Munoz JL, Caines VV. Cocaine-stimulated endothelin-1 is decreased by angiotensin-converting enzyme inhibitors in cultured endo-thelial cells. Cardiovasc Res. 1996;31:117-123.
66. Yoon SH, Zuccarello M, Rapoport RM. Acute cocaine induces endothelin-1 dependent constriction of rabbit basilar artery. Endothelium. 2007;14:137-139.
67. Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J. 2001;142:402-410.
68. Howard RE, Hueter DC, Davis GC. Acute myocardial infarction following cocaine abuse in young woman with normal coronary arteries. JAMA. 1985;254:95-96.
69. Garfia A, Valverde JL, Borondo JC, Candenas I, Lucena J. Vascular lesions in intestinal ischemia induced by cocaine-alcohol abuse: report of a fatal cause due to overdose. J Forens Sci. 1990;35, 740-745.
70. Tazelaar HD, Karch SB, Stephens BG, Billingham M. Cocaine and the heart. Hum Pathol. 1987;18:195-199.
71. Crowley JP. Coagulopathy and bleeding in the parturient patient. Rhode Island Med J. 1989;72:135-143.
72. Heesch CM, Wilhelm CR, Ristich J, Adnane J, Bontempo FA, Wagner WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000;83:688-695.
73. Zimmerman FH, Gustafson GM, Kemp HG. Recurrent myo-cardial infarction associated with cocaine abuse in a young man with normal coronary arteries: evidence for coronary artery spasm culminating in thrombosis. Am ColI Cardiol. 1987;2:964-968.
74. Billman GE, Lappi MD. Effects of cocaine on cardiac vagal tone before and during coronary artery occlusion: cocaine exacerbates the autonomic response to myocardial ischemia. J Cardiovasc Pharmacol. 1993;22:869-876.
75. Howard RE, Hueter DC, Davis GC. Acute myocardial infarction following cocaine abuse in a young woman with normal coronary arteries. JAMA. 1985;254:95-96.
76. Chao CR. Cardiovascular effects of cocaine during pregnancy. Semin Perinatol. 1996;20:107-114.
77. Wood JR Jr, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA. 1987;257:957-961.
78. Billman GE, Hoskins RS. Cocaine-induced ventricular fibrillation: protection afforded by the calcium antagonist verapamil. FASEB J. 1988;2:2990-2995.
79. Zhao Y, Sun L. Perinatal cocaine exposure reduces myocardial norepinephrine transporter function in the neonatal rat. Neurotoxicol Teratol. 2004;26:443-450.
80. Tomita F, Bassett AL, Myerburg RJ, Kimura S. 1993. Effects of cocaine on sarcoplasmic reticulum in skinned rat heart muscle. Am J Heart Circ Physiol. 1993;264:H845-H850.
81. Richards IS, Kulkarni AP, Bremner WF. Cocaine-induced arrhythmias in human fetal myocardium in vitro: possible mechanism for fetal death in utero. Pharmacol Toxicol. 1990;66:150-154.
82. Needlman R, Frank DA, Cabral H, Mirochnick M, Kwon C, Zuckerman B. Blood pressure in children exposed prenatally to cocaine. Clin Pediatr. 1998;37:659-664.
83. Billman GE. Effect of calcium channel antagonists on cocaine-induced malignant arrhythymias: protection against ventricular fibrillation. J Pharmacol Exp Ther. 1993;266:407-416.
84. Wetli CV, Wright RK. Death caused by recreational cocaine use. JAMA. 1979;241:2519-2522.
85. Wood DM, Dargan PI, Hoffman RS. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila). 2009;47:14-23.
86. Castro VJ, Nacht R. Cocaine-induced bradyarrhythmia: an unsuspected cause of syncope. Chest. 2000;117:275-277.
87. Coleman DJ, Ross TF, Naughton JL. Myocardial ischemia and infarction related to recreational cocaine use. West J Med. 1982;136:444-446.
88. Rezkalla SH, Kloner RA. Cocaine-induced acute myocardial infarction. Clin Med Res. 2007;5:172-176.
89. Aslibekyan S, Levitan EB, Mittleman MA. Prevalent cocaine use and myocardial infarction. Am J Cardiol. 2008;102:966-969.
90. Pilati CF, Clark RS, Gilloteaux J, Bosso FJ, Holcomb P, Maron MB. Excessive sympathetic nervous system activity decreases myocardial contractility. Proc Soc Exp BioI Med. 1990;193:225-231.
91. Lepsch LB, Munhoz CD, Kawamoto EM, et al. Cocaine induces cell death and activates the transcription nuclear factor kappa-b in PC12 cells. Mol Brain. 2009;2:1-15.
92. Dey S, Mactutus CF, Booze RM, Snow DM. Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signalling. Neuroscience. 2007;144:509-521.
93. 2+ transport. Arch Biochem Biophys. 2000;387:85-92.
94. Xiao Y, Xiao D., He J, Zhang L. Maternal cocaine administration during pregnancy induces apoptosis in fetal rat. J Cardiovasc Pharmacol. 2001;37:639-648.
95. Shite J, Qin F, Mao W, Kawai H, Stevens SY, Liamg C. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardio.l 2001;38:1734-1740.
96. Datillo PB, Hailpern SM, Fearon K, Sohal D, Nordin C. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51:117-125.
97. Gilloteaux J, Jamison JM, Ervin E, Arnold D, Docherty JJ, Summers JL. Cancer cell necrosis by autoschizis: synergism of antitumor activity of vitamin C: vitamin K3 on human bladder carcinoma T24 cells. Scanning Microsc. 1998;20: 564-575.
98. Gilloteaux J, Jamison JM, Arnold D, Taper HS, Summers JL Ultrastructural aspects of autoschizis: a new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells. Ultrastruct Pathol. 2001;25:183-192.
99. Gilloteaux J, Jamison JM, Arnold D, Neal DR, Summers JL. Morphology and DNA degeneration during autoschizic cell death in bladder carcinoma T24 cells induced by ascorbate and menadione treatment. Anat Rec A Discov Mol Cell Evol Biol. 2006;288:58-83.
100. Zhang L, Xiao Y, He J. Cocaine and apoptosis in myocardial cells. Anat Rec (New Anat). 1999;257:208-216.
101. Li G, Xiao Y, Zhang L. Cocaine induces apoptosis in fetal rat myocardial cells through the p38 mitogen-activated protein kinase and mitochondrial/ cytochrome c pathways. J Pharmacol Exp Ther. 2005;312:112-119.
102. Welder AA, Smith MA, Ramos K, Acosta D. Cocaine-induced cardiotoxicity in vitro. Toxicol in Vitro. 1988;1:205-213.
103. Fajardo LF. The complexity of endothelial cells: a review. Am J Clin Pathol. 1989;92:241-250.
104. Condorelli G, Borello U, De Angelis L, et al. Cardiomyocytes induce endothelial cells to transdifferentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci USA. 2001;98:10733-10738.
105. Feng Q. Postnatal consequences of prenatal cocaine exposure and myocardial apoptosis: does cocaine in utero imperil the adult heart? Br J Pharmacol. 2005;144, 887-888.
106. Phillips CF, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9:177-196.